EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Prognostic Characteristics of Metabolic Dysfunction-Associated Steatotic Liver in Patients with Obesity Who Undergo One Anastomosis Gastric Bypass Surgery: A Secondary Analysis of Randomized Controlled Trial Data

Silke Crommen, Karl Peter Rheinwalt iD, Andreas Plamper iD, Daniela Rösler iD, Leonie Weinhold, Christine Metzner, Sarah Egert iD

Nutrients · 2024

DOI: 10.3390/nu16183210 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Silke Crommen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nutritional and Food Sciences, Nutritional Physiology, University of Bonn, 53113 Bonn, Germany. Hauptthemen laut MEDLINE: Gastric Bypass, Insulin Resistance, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FormMed HealthCare AG, Frankfurt, Germany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity and insulin resistance (IR). Identifying characteristics that predict a higher risk of fibrosis using noninvasive methods is particularly important.

Methods

We performed a secondary analysis of data from an RCT of 48 patients after one anastomosis gastric bypass (OAGB) surgery, supplemented with specifically formulated probiotics and micronutrients or control treatment for 12 weeks. Patients were categorized using alanine aminotransferase (ALAT; >35 U/L for women, >50 U/L for men), higher NAFLD fibrosis score (NFS) > −1.455), and IR (HOMA-IR > 2.0). This trial was registered at Clinicaltrials.gov (ID: NCT03585413).

Results

Abnormal ALAT was associated with high triglycerides, blood pressure (BP), glucose, and fatty liver index (FLI). NFS > −1.455 was linked to higher age, body mass, waist circumference, and FLI, and lower albumin and platelet count. HOMA-IR > 2.0 was associated with higher BP and triglycerides, lower HDL-cholesterol, higher serum transaminases, and higher probabilities of steatosis and fibrosis. Twelve weeks postoperatively, patients with NFS > −1.455 showed greater reductions in body mass, systolic BP, serum insulin, and HbA1c, whereas those with NFS ≤ −1.455 showed improvements in FLI and lipid metabolism but had high glucose concentrations. Patients with HOMA-IR ≤ 2.0 also had high glucose concentrations.

Conclusions

The evaluation of common biomarker scores for fibrosis and IR may help clinicians to recognize severe NAFLD and improve the outcomes of OAGB surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric BypassInsulin ResistanceNon-alcoholic Fatty Liver DiseaseHumansFemaleMaleMiddle AgedAdultPrognosisObesityAlanine TransaminaseObesity, MorbidLiver CirrhosisBlood Glucose

Stichwörter der Autor:innen

bariatric surgeryinsulin resistancemetabolic dysfunction-associated steatotic liver diseasemini gastric bypassnonalcoholic fatty liver diseaseone anastomosis gastric bypass

Substanzen

Alanine TransaminaseBlood Glucose

Autor:innen und Institutionen

  • Institute of Nutritional and Food Sciences, Nutritional Physiology, University of Bonn, 53113 Bonn, Germany.
  • Department of Bariatric, Metabolic and Plastic Surgery, Cellitinnen-Krankenhaus St. Franziskus Cologne, 50825 Cologne, Germany.
  • Bonn Education Association for Dietetics r.A., 50935 Cologne, Germany.
  • Institute of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, 53127 Bonn, Germany.
  • Medical Clinic III-Department of Gastroenterology, Metabolic Disorders and Internal Intensive Care, University Hospital RWTH Aachen, 52074 Aachen, Germany.

ORCID-Profile: Karl Peter Rheinwalt, Andreas Plamper, Daniela Rösler, Sarah Egert

Förderung

  • FormMed HealthCare AG, Frankfurt, Germany

Zitieren

APA

Crommen, S., Rheinwalt, K. P., Plamper, A., Rösler, D., Weinhold, L., Metzner, C., & Egert, S. (2024). Prognostic Characteristics of Metabolic Dysfunction-Associated Steatotic Liver in Patients with Obesity Who Undergo One Anastomosis Gastric Bypass Surgery: A Secondary Analysis of Randomized Controlled Trial Data. Nutrients. https://doi.org/10.3390/nu16183210

Vancouver

Crommen S, Rheinwalt KP, Plamper A, Rösler D, Weinhold L, Metzner C, et al. Prognostic Characteristics of Metabolic Dysfunction-Associated Steatotic Liver in Patients with Obesity Who Undergo One Anastomosis Gastric Bypass Surgery: A Secondary Analysis of Randomized Controlled Trial Data. Nutrients. 2024. doi:10.3390/nu16183210

BibTeX
@article{Crommen2024,
  author = {Crommen, Silke and Rheinwalt, Karl Peter and Plamper, Andreas and Rösler, Daniela and Weinhold, Leonie and Metzner, Christine and Egert, Sarah},
  title = {Prognostic Characteristics of Metabolic Dysfunction-Associated Steatotic Liver in Patients with Obesity Who Undergo One Anastomosis Gastric Bypass Surgery: A Secondary Analysis of Randomized Controlled Trial Data},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16183210}
}
Kostenlos starten →